Aruna Co-Founder Dr. Steven Stice Inducted into AIMBE College
31 Mar 2025 //
GLOBENEWSWIRE
Aruna Bio Gets US Patent For Neural Exosomes To Reduce Brain Inflammation
19 Aug 2024 //
GLOBENEWSWIRE
Aruna Bio Patents Neural Exosomes For Brain Drug Delivery
16 Jul 2024 //
GLOBENEWSWIRE
Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors
03 Jun 2024 //
GLOBENEWSWIRE
Aruna Bio to Present at BIO International Convention 2024
28 May 2024 //
GLOBENEWSWIRE
Aruna Bio to Participate in Upcoming Investor Conferences
18 Mar 2024 //
GLOBENEWSWIRE
Aruna BIO Establishes Stroke Advisory Board
04 Mar 2024 //
GLOBENEWSWIRE
Aruna Bio Announces FDA Clearance of IND for Lead Program AB126
16 Jan 2024 //
GLOBENEWSWIRE
Aruna Bio to Participate in the BIO Investor Forum in October 2023
10 Oct 2023 //
GLOBENEWSWIRE
Aruna Bio Announces Presentation on the Mechanism of its Neural Exosome Platform
18 Sep 2023 //
GLOBENEWSWIRE
Aruna Bio Announces Preclinical Results from Pilot Study Evaluating AB126
07 Sep 2023 //
GLOBENEWSWIRE
Aruna Announces Presentation on Opportunities for its Neural Exosome Platform
05 Sep 2023 //
GLOBENEWSWIRE
Aruna Announces Presentation on Treatment Opportunities of Lead Program, AB126
15 Aug 2023 //
GLOBENEWSWIRE
Aruna Bio Announces Appointment of Mike Ryan to its Board of Directors
19 Dec 2022 //
GLOBENEWSWIRE
Aruna Bio Announces Presentation on Neural Exosome Treatment Opportunities
06 Oct 2022 //
GLOBENEWSWIRE
Aruna Bio Bags A New Composition Of Matter Patent Covering Neural Exosomes
13 Jun 2022 //
PRNEWSWIRE